key: cord-0972072-e4m43r1l
authors: Kato, Yoji; Higashiyama, Akari; Takaoka, Emi; Nishikawa, Miyu; Ikushiro, Shinichi
title: Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro
date: 2021-10-08
journal: Advances in redox research : an official journal of the Society for Redox Biology and Medicine and the Society for Free Radical Research-Europe
DOI: 10.1016/j.arres.2021.100021
sha: 5f731f825986574305f98a20484565f94f5ab670
doc_id: 972072
cord_uid: e4m43r1l

SARS-CoV-2 main protease is a possible target for protection against viral infection. This study examined the inhibitory effect of food phytochemicals on the main protease of SARS-CoV-2 by determining a cleaved product after chromatographic separation. First, 37 phytochemicals, including glycosides and metabolites, were screened at 20 µM; epigallocatechin gallate, myricetin, theaflavin, herbacetin, piceatannol, myricitrin, and isothiocyanates inhibited the enzyme in varying degrees. The IC50 values were estimated from 0.4 to 33.3 µM against the 0.5-µM enzyme. The dose-dependent adduction of epigallocatechin gallate and myricetin was confirmed by quinone staining of protein blotted onto a membrane. The enzyme activity was decreased by increasing the concentration of the two phytochemicals, accompanied by increasing the respective adducted molecule estimated by intact mass spectrometry. Reduced glutathione canceled the formation of conjugate and the inhibitory effect of epigallocatechin gallate or myricetin on the enzyme, suggesting that the formation of the quinone moiety in the phytochemicals is critical for the inhibition. The covalent binding of epigallocatechin gallate or myricetin to the cysteine residue at the active site was confirmed by analyzing peptides from the chymotrypsin-digested main protease.

SARS-CoV-1 (classic) or MERS-CoV have been reported; some flavonoids, including herbacetin and quercetin 3-O-glucoside, inhibited MERS-CoV M pro [5] . SARS-CoV-1 M pro was inhibited by flavonoids and flavones, such as herbacetin, rhoifolin, pectolinarin, apigenin, luteolin, quercetin, and amentoflavone [6, 7] . Concerning SARS-CoV-2 M pro , epigallocatechin gallate (EGCG) [8, 9] , theaflavin [8] , myricetin [10] , quercetin [11] , herbacetin, pectolinarin, baicalin [12] , rutin, baicalein [13] , and cyanidin-3-glucoside [14] shows inhibitory effects on the enzyme in vitro. Most research was performed by fluorescence resonance energy transfer (FRET) assay, which sometimes results in false negatives or positives due to the interference of fluorescence signals derived from test chemicals [15] ; a competitive binding assay using the fluorescent probe 8-anilinonaphthalene-1-sulfonate is also reported [13] .

The study examines the inhibitory effect of food phytochemicals by directly measuring the digested peptide substrate after high-performance liquid chromatography (HPLC) separation. Additionally, the mechanism of inhibition by covalent adduction of phytochemicals, such as EGCG and myricetin, was estimated by quinone staining and mass spectrometry (MS).

Dabcyl-KTSAVLQSGFRKME-Edans was purchased from GL Biochem, Ltd. 

The MBP-tagged main protease containing SARS-CoV-2 M pro (GenBank Accession No.

YP_009725301; Met1-Gln306) was constructed using pMAL-c2 expression vector (New England Biolabs Japan Inc. Fig. 1 ). The concentration of each protein was estimated by bicinchoninic acid protein assay.

The enzymatic reaction was performed in a 20-mM Tris-HCl buffer containing 1-mM ethylenediaminetetraacetic acid (EDTA), 150-mM NaCl, and 0.01% Triton X-100 (pH 7.5). All tested chemicals were dissolved in dimethyl sulfoxide (DMSO), and the concentration of DMSO was 2% in the reaction mixture, unless otherwise indicated. Finally, the eluate was introduced into the Q-TOF mass spectrometer and analyzed using information-dependent analysis mode.

The MBP-cleaved enzyme (0.5 µM) was incubated with a test chemical (0-5 µM, typically 1 µM) in Tris-HCl buffer as shown above for 30 min at 37°C. The protein (10 µL) was separated using a Phenomenex bioZen Intact XB-C8 column (2.1 × 100 mm, 3.6 µm) for gradient elution using 0.1% formic acid in water (solvent A) and 0.1% formic acid in CH 3 CN (solvent B) at a flow rate of 0.3 mL/min connected to the MS.

The gradient program was as follows: initial B5%, 0.5 min B5%, 4 min B90%, 5 min B5%, and 8 min B5%. The eluate was introduced into the MS using TOF-positive mode.

This experiment was performed twice. The deconvolution of the mass spectrum was acquired by UniDec (v.4.4.1) [18] .

After incubating the enzyme with the test chemical, 10-mM dithiothreitol and ×4

Laemmli sample loading buffer (Bio-Rad, CA, USA) were added to the reaction mixture. The sample (60-ng protein/lane) and Precision Plus Protein Dual Color Standard (Bio-Rad) were then applied to an SDS-polyacrylamide gel (SDS-PAGE, 10% acrylamide) and then migrated by electrophoresis. The proteins in gels were blotted onto a PVDF membrane (Immobilon-P, Merck), and quinones on the membrane were stained using NBT (0.24 mM) in 2-M glycine-NaOH (pH 10) as described previously [19, 20] . The same samples were separated using a gel, and the proteins in the gel were stained using Flamingo Stain (Bio-Rad) according to the manufactures' protocol.

Detection was performed using a LAS1000 plus (Fujifilm, Tokyo, Japan). This experiment was performed twice.

Detection of free thiols in the enzyme was performed as described previously with some 

The MBP-cleaved enzyme (5 µM) was incubated with EGCG/myricetin (10 µM) in the Tris-HCl buffer at 37°C for 30 min. The reaction mixture (50 µL) was then applied to a tube for centrifugal ultrafiltration (Amicon Ultra 10K, Merck). Then, 450-µL 0.1-M Tris-HCl containing 10-mM CaCl 2 (pH 8.0) was added and centrifuged to exchange the buffer for digestion. To the protein fraction, 100-µL chymotrypsin (1.7 µg) in buffer containing 0.025% ProteaseMAX was added and then further incubated at 25°C for 6 h.

The digested sample was purified using a peptide desalting and enrichment Tip, GL-Tip SDB (GL Sciences Inc., Tokyo, Japan) according to the manufacturers' protocol. 

To examine the inhibitory effect of 37 phytochemicals on M pro (MBP-tagged M pro ), Dabcyl-KTSAVLQSGFRKME-Edans was used as a substrate, and the formed cleaved peptide (SGFRKME-Edans) was then estimated using an HPLC fluorescence detector. Before the screening, the generation of cleaved peptides (Dabcyl-KTSAVLQ and SGFRKME-Edans), as products, was confirmed by TOF-MS. Next, the adduction of EGCG and myricetin to the enzyme was confirmed by quinone staining. After the reaction of the M pro enzyme with the two phytochemicals, the M pro was subjected to gel electrophoresis, blotted onto a PVDF membrane, and then stained with NBT (Fig. 2B) . From 0.625-µM phytochemicals, NBT-reactive quinone moieties at the location of M pro were observed dose-dependently. Simultaneously the free thiols in the M pro were decreased by increasing the concentration of phytochemicals.

Most of the enzyme activity was retained when reduced glutathione (GSH, 1 mM) was added to the buffer in advance (Fig. 3C) . Additionally, the control enzyme activity was approximately increased 1.3-fold by GSH supplementation (data not shown). Quinone staining by EGCG/myricetin was also canceled when incubated in the presence of GSH.

The enzyme (5 µM 3B (b) ), and the fragmentation patterns ( Fig. 3B (d, f)) were matched with the predicted myricetin-adducted NGSCGSVGF and LNGSCGSVGF.

The viral M pro is a promising target for preventing the infection of coronavirus, Of the chemicals tested, the inhibitory activities of some phytochemicals have already been examined at a 200-µM concentration by FRET assay [25] . In contrast, current results using 37 compounds differ from the outcome in some points. It might be due to the difference in the evaluation method of enzyme activity. In this study, at 20 µM, myricetin, EGCG, theaflavin, and BITC considerably inhibited the viral protease, and to a lesser extent, piceatannol, PEITC, herbacetin, baicalein, myricitrin, and AITC.

Furthermore, the patterns of inhibition and adduct formation were relatively matched ( Fig. 1AB ). In addition, as mentioned before, most of these phytochemicals have been reported as possible inhibitors of M pro .

This study also focused on intact phytochemicals and their metabolites because ingested phytochemicals are often metabolized into conjugates, such as glucuronide or sulfate formed by intracellular phase II enzymes in cells. Possible inhibitory effects of these metabolites by a flavonoid have already been supposed by in silico study [26, 27] , and baicalin, a glucuronide of baicalein, inhibits SARS-CoV-2 recombinant M pro in vitro [12] . However, most metabolites or the glucosides of flavonoids examined, except for myricitrin (a rhamnoside of myricetin), did not inhibit the enzyme at the concentration tested (20 µM). Among the circulating metabolites, the glucuronides could be cleaved at the inflammatory site by a secreted -glucuronidase and then regenerate aglycone [28, 29] . The sulfate form of phytochemicals could restore the original phytochemical in cells [30] . These probably suggest that glucuronides or sulfates of phytochemicals, which are often abundantly present in blood compared with phytochemical (aglycone), are possibly converted to the active hydrophobic aglycone form and then incorporated into an infected cell.

When EGCG, myricetin, theaflavin, and piceatannol (1 µM) were mixed with 0.5-µM enzyme for 30 min at neutral pH, the adduct was formed (Fig. 1B) . We have also found that myricetin and EGCG inhibit the M pro enzyme accompanying the formation of one or two molecules adducted to the enzyme molecule dose-dependently (Fig. 2) . The autoxidation of catechin or flavonoid generates a quinone moiety. The formed quinone could react with a thiol of the enzyme, resulting in the enzyme conjugation with the phytochemical (Fig. 4) [31] . Piceatannol is abundantly present in the fruit of Passiflora edulis [32] and is a metabolite of resveratrol. In this study, we have discovered that piceatannol inhibits the enzyme; the catechol structure of piceatannol is presumably the critical structure for conjugation.

Pyrogallol (myricetin and its synthetic derivative) is considered an alternative warhead in the design of targeted covalent ligands [10] . EGCG has trihydroxy benzoyl moieties at the B and D rings. The liberation of the galloyl moiety (Δ170) at the D ring was observed in fragments of digested peptides conjugated with EGCG ( Fig. 3A (c, e) ), and similar liberation of the galloyl moiety (Δ170) from EGCG-adducted MHRQETVDC was already reported [21] . In contrast, a signal generated from the liberation of Δ290 from the opposite side (A, B, and C rings) was not observed (data not shown). Thus, this indicates that EGCG was mainly conjugated with a protein thiol via the galloyl moiety at the B ring. Additionally, by comparing myricetin with myricitrin, sugar moiety in the phytochemical weakens its inhibitory activity. Formerly, in a lipid oxidation system, myricetin and thiol conjugates were identified [33] . Recently, the conjugation (Δ316 Da) of one molecule of myricetin to M pro evaluated by intact MS has been reported [10] , and the mechanism of conjugation of myricetin with protein thiol via the formation of o-quinone is also proposed.

Quinone staining showed that a reduced type of glutathione (GSH) suppressed the conjugation of EGCG/myricetin (Fig. 2C) . Furthermore, enzyme activity loss by EGCG/myricetin was canceled in the presence of GSH. These results suggested that GSH reacted with the o-quinone moiety of the phytochemical instead of a thiol in the enzyme. Thus, quinones were probably reactants to the enzyme.

We attempted to identify EGCG or myricetin-adducted site in the enzyme by chymotrypsin digestion (Fig. 3) . A former study showed that ebselen, PX-12, and carmofur adduct to Cys145, which was assigned by analyzing TIKGSFLNGSCGSVGF or FTIKGSFLNGSCGSVGF digest by chymotrypsin [3] . We have found that the EGCG/myricetin-adducted peptides (0 and 1 missed cleavage) are located at the active site of M pro , (L)NGSCGSVGF. Furthermore, this is the first report that phytochemicals covalently adduct the active site of M pro .

The inhibitors, ebselen, disulfiram, carmofur, PX-12, tideglusib and shikonin, were found to be nonspecific promiscuous SARS-CoV-2 main protease inhibitors because they lose their activities in the presence of a reducing reagent like dithiothreitol [34] . In contrast, ebselen and its derivative possess M pro inhibitory and antiviral activities [35] . The favored reaction between quinone and an enzyme thiol may lead to off-target effects; quinones of phytochemicals may be trapped by intravital GSH, cysteine, or protein thiols before approaching the viral enzyme in infected cells. Then, a thiol-sensitive oxidized phytochemical may be classified as a nonspecific inhibitor of the M pro enzyme. However, it has also been reported that the reaction rate of myricetin with GSH is slow [10] . Additionally, in vivo environment is more hypoxic (reductive) than in vitro test tubes. Furthermore, there are many causes of oxidation of phytochemicals in intra-and extracellular environments [36] ; therefore, quinone form of phytochemicals could react with the viral thiol enzyme under higher oxidative stress.

The inhibitory effect of ITC including PEITC on M pro has been reported [37, 38] . This study also shows that three ITCs prevent cleaved peptide generation. As already known, ITC is highly reactive to thiols, forming a covalent ITC-thiol adduct.

Therefore, the modification of cysteine at the active site by ITC would inactivate the enzyme. However, the adducts were not observed at least at 1-µM ITC (Fig. 1B) ,

probably because the thiocarbamoyl linkage between ITC and thiol is unstable. ITC also reacts with amines to a lesser extent [39, 40] . Therefore, the study on the effect of ITC on the enzyme remains unelucidated.

It has been reported that the plasma concentration of total polyphenol metabolites ranged from 0 to 4 µM with an intake of 50-mg aglycone equivalents [41] .

Therefore, it may not be enough to deliver these possible functional phytochemicals to infected cells. However, current results have shown that some phytochemicals at a physiological concentration, a few µMs, inhibit the viral enzyme in vitro. Furthermore, former studies have shown that cellular proteins were modified by 5-40-µM catechins, including EGCG, supplemented to the culture medium [21, 42] , suggesting that EGCG (and other phytochemicals) could penetrate the cell and covalently modify cellular proteins. Besides, nanodelivery systems with food phytochemicals may also overcome the issue of lower bioavailability [43] .

A limitation of this study is that the inhibition was tested by incubating the recombinant enzyme with pure phytochemicals in vitro. Therefore, using [44] is preferable; however, it requires a higher biosafety, such as biosafety level-3 environment. Alternatively, a cell-based Flip-GFP and cell-based luciferase-Glo assays for M pro have been developed [45] [46] [47] [48] [49] . These novel assay systems could validate the inhibitory effects of the phytochemicals.

Conclusively, we have estimated the inhibitory effect of the phytochemicals on the virus recombinant main protease by measuring the generation of the intact fluorescent-cleaved peptide substrate. It was found that some phytochemicals, including myricetin and EGCG, significantly inhibited the enzyme even at a physiological concentration. Furthermore, the covalent phytochemical-M pro adducts were observed along with the decrease in enzyme activity, and the adduction happened at the Cys of the active site of M pro . Finally, verifying in vivo occurrences of the reaction between phytochemicals and the viral enzyme should be a subject for future studies.

There is no conflict of interest. 

This work is partly supported by grants from the Ijima Memorial Foundation for the Promotion of Food Science and Technology. We are thankful to Motonori Tsuji (Institute of Molecular Function) for his preliminary in silico study and helpful advice.

We are also grateful to Chisato Yakemoto and Professor Mikiko Ito for their contribution to a preliminary study. 

Reversal of the progression of fatal coronavirus infection in cats by a broad-spectrum coronavirus protease Inhibitor

3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice

Structure of M(pro) from SARS-CoV-2 and discovery of its inhibitors

Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved alpha-ketoamide inhibitors

Characteristics of flavonoids as potent MERS-CoV 3C-like protease inhibitors

Inhibition of SARS-CoV 3CL protease by flavonoids

Biflavonoids from Torreya nucifera displaying SARS-CoV 3CL(pro) inhibition

Tea polyphenols EGCG and theaflavin inhibit the activity of SARS-CoV

The inhibitory effects of PGG and EGCG against the SARS-CoV-2 3C-like protease

Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease

Structural stability of SARS-CoV-2 3CLpro and identification of quercetin as an inhibitor by experimental screening

Flavonoids with inhibitory activity against SARS-CoV-2 3CLpro

Interaction of 8-anilinonaphthalene-1-sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification

Interaction of small molecules with the SARS-CoV-2 main protease in silico and in vitro validation of potential lead compounds using an enzyme-linked immunosorbent assay

Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication

An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19, medRxiv (2021) 2021

The Inhibitory effects of plant derivate polyphenols on the main protease of SARS coronavirus 2 and their structure-activity relationship

Flavonoid glycosides and their putative human metabolites as potential inhibitors of the SARS-CoV-2 main protease (Mpro) and RNA-dependent RNA polymerase (RdRp)

Potential bioactive glycosylated flavonoids as SARS-CoV-2 main protease inhibitors: A molecular docking and simulation studies

Dynamics of the cellular metabolism of leptosperin found in manuka honey

Covalent adduction of endogenous and food-derived quinones to a protein: its biological significance

Extract of passion fruit (Passiflora edulis) seed containing high amounts of piceatannol inhibits melanogenesis and promotes collagen synthesis

Enhancing Effect of a Cysteinyl Thiol on the Antioxidant Activity of Flavonoids and Identification of the

PX-12, Tideglusib, and Shikonin Are Nonspecific Promiscuous SARS-CoV-2 Main Protease Inhibitors

Inhibition mechanism of SARS-CoV-2 main protease by ebselen and its derivatives

Formation and biological targets of quinones: cytotoxic versus cytoprotective effects

A Ligand Selection Strategy Identifies Chemical Probes Targeting the Proteases of SARS-CoV-2

Identification of inhibitors of SARS-CoV-2 3CL-Pro enzymatic activity using a small molecule in vitro repurposing screen

Covalent modification of lysine residues by allyl isothiocyanate in physiological conditions: plausible transformation of isothiocyanate from thiol to amine

Covalent modification of phosphatidylethanolamine by benzyl isothiocyanate and the resultant generation of ethanolamine adduct as its metabolite

Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies

Epigallocatechin-3-gallate suppresses growth of AZ521 human gastric cancer cells by targeting the DEAD-box RNA helicase p68

Bioavailability enhancement of EGCG by structural modification and nano-delivery: A review

A small SARS-CoV-2 and blocks virus replication

Rational Design of Hybrid SARS-CoV-2 Main Protease Inhibitors Guided by the Superimposed Cocrystal Structures with the Peptidomimetic Inhibitors GC-376, Telaprevir, and Boceprevir

Cell-based high-throughput screening protocol for discovering antiviral inhibitors against SARS-COV-2 main protease

Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CL(pro) Inhibitors

Validation and invalidation of SARS-CoV-2 main protease inhibitors using the Flip-GFP and Protease-Glo luciferase assays, bioRxiv (2021) 2021

A protease-activatable luminescent biosensor and reporter cell line for authentic SARS-CoV-2 infection